Latest Market Research News

Strategic Elements has achieved a significant milestone with the granting of a patent in Japan for its Energy Ink™ moisture energy platform, reinforcing its foothold in a critical electronics market and advancing its battery-free device ambitions.

JPMorgan Asset Management has released updated estimated annual cash distributions for six of its ASX-listed ETFs for the financial year ending 30 June 2026, with amounts varying widely between funds and one yielding no distribution.

Fortuna Metals has commissioned its own laboratory in Malawi, accelerating sample processing and cutting assay costs as it nears a maiden resource estimate for its Mkanda rutile and graphite project.

International Graphite Ltd (ASX:IG6) has partnered with Alkeemia S.p.A. to establish a graphite processing facility in Italy, aiming for first production in the second half of 2027 and a final investment decision by Q3 2026.

Unith Ltd (ASX:UNT) posted Q3 FY2026 revenue of A$1.26 million, secured a $2 million finance facility to fuel commercial expansion, and showcased significant advancements in its AI Digital Humans platform, including proprietary streaming technology and SDK launches.

EVE Health Group has begun commercial sales of Libbo, an oral dissolving film for erectile dysfunction, supported by a new digital men’s health platform. The company also expanded its pharmaceutical pipeline and secured $1.3 million in fresh capital to fund ongoing development and commercialization.

Gateway Mining attributes recent share price gains to a newly published independent research report, while confirming ongoing assay results from its Yandal Project remain under review and will be disclosed progressively starting 22 April 2026.

DXN Limited has secured a A$5.3 million contract to deliver a modular Cable Landing Station in South America, marking its first foray into the Latin American market and reinforcing its role in hyperscale internet infrastructure.

EBR Systems marked a pivotal transition in 2025 with FDA approval of its WiSE CRT System and the initiation of U.S. commercial implants, generating $1.6 million in revenue. Despite this progress, the company reported a net loss of $48.8 million and completed a significant capital raise to support ongoing growth.

Botanix Pharmaceuticals reports a surge in Sofdra sales driving revenue to $16.5 million, yet the company records a $33.2 million loss amid expanded marketing and operational costs. A $45 million capital raise aims to support growth and supply chain improvements.

Aland Equity Group reported a sharp revenue decline and an 85% increase in losses for the half-year ending December 2025, while completing a major capital raise and reshuffling its board.

Pureprofile Ltd reported a robust 14.2% increase in revenue and a 21.6% rise in net profit for H1 FY26, driven by international expansion and AI-powered platform growth. The company also announced a strategic acquisition to deepen its market research capabilities.